1-12 of 12
Fang Fang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA

Shifeng Lian, Chenyu Lu, Fugui Li, Xia Yu, Limei Ai, Biaohua Wu, Xueyi Gong, Wenjing Zhou, Xuejun Liang, Jiyun Zhan, Yong Yuan, Fang Fang, Zhiwei Liu, Mingfang Ji, Zongli Zheng
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (13): 2772–2779.
https://doi.org/10.1158/1078-0432.CCR-23-3449
Published: 01 July 2024
View article titled, Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA
Open the PDF for Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA in another window
Includes: Supplementary data
Journal Articles

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations

Nicholas Pulliam, Fang Fang, Ali R. Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B. Baylin, Daniela Matei, Harikrishna Nakshatri, Feyruz V. Rassool, Kathy D. Miller, Kenneth P. Nephew
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (13): 3163–3175.
https://doi.org/10.1158/1078-0432.CCR-18-0204
Published: 01 July 2018
View article titled, An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations
Open the PDF for An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations in another window
Includes: Supplementary data
Journal Articles

Abstract AP14: THERAPEUTIC TARGETING USING TUMOR SPECIFIC PEPTIDES INHIBITS LONG NON–CODING RNA HOTAIR ONCOGENIC ACTIVITY IN OVARIAN CANCER

Ali R. Özeş, Yinu Wang, Fang Fang, Kenneth P. Nephew
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP14.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP14
Published: 31 May 2017
View article titled, Abstract AP14: THERAPEUTIC TARGETING USING TUMOR SPECIFIC PEPTIDES INHIBITS LONG NON–CODING RNA HOTAIR ONCOGENIC ACTIVITY IN OVARIAN CANCER
Journal Articles

Abstract B39: Identification and targeting mediators of chemoresistance using the patient-derived xenograft model of ovarian cancer

Zachary Dobbin, Robert Cornelison, Ashwini K. Katre, David A. Schneider, Karen Watters, Fabian Coscia, Ernst Lengyel, Aaron Buechlein, Fang Fang, Kenneth Nephew, Charles N. Landen, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B39.
https://doi.org/10.1158/1557-3265.PDX16-B39
Published: 15 August 2016
View article titled, Abstract B39: Identification and targeting mediators of chemoresistance using the patient-derived xenograft model of ovarian cancer
Journal Articles

Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer

Donghao Lu, Jennifer A. Sinnott, Unnur Valdimarsdóttir, Fang Fang, Travis Gerke, Svitlana Tyekucheva, Michelangelo Fiorentino, Mats Lambe, Howard D. Sesso, Christopher J. Sweeney, Kathryn M. Wilson, Edward L. Giovannucci, Massimo Loda, Lorelei A. Mucci, Katja Fall
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 765–772.
https://doi.org/10.1158/1078-0432.CCR-15-0101
Published: 31 January 2016
View article titled, Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
Open the PDF for Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A70: Epigenome and genome alterations in platinum resistant ovarian tumors.

Fang Fang, Horacio Cardenas, Dave Miller, Aaron Buechlein, Qing Yu, Yunlong Liu, Guanglong Jiang, Pietro Taverna, Harold Keer, Doug Rusch, Daniela Matei, Kenneth P. Nephew
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A70.
https://doi.org/10.1158/1557-3265.OVCA15-A70
Published: 15 January 2016
View article titled, Abstract A70: Epigenome and genome alterations in platinum resistant ovarian tumors.
Journal Articles

Abstract POSTER-THER-1421: Epigenetic targeting of ovarian cancer stem cells

Yinu Wang, Horacio Cardenas, Fang Fang, Salvatore Condello, Pietro Taverna, Matthew Segar, Yunlong Liu, Daniela Matei, Kenneth P. Nephew
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-THER-1421.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-THER-1421
Published: 15 August 2015
View article titled, Abstract POSTER-THER-1421: Epigenetic targeting of ovarian cancer stem cells
Journal Articles

The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer

Fang Fang, Joanne Munck, Jessica Tang, Pietro Taverna, Yinu Wang, David F.B. Miller, Jay Pilrose, Gavin Choy, Mohammad Azab, Katherine S. Pawelczak, Pamela VanderVere-Carozza, Michael Wagner, John Lyons, Daniela Matei, John J. Turchi, Kenneth P. Nephew
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6504–6516.
https://doi.org/10.1158/1078-0432.CCR-14-1553
Published: 14 December 2014
View article titled, The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
Open the PDF for The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer in another window
Includes: Supplementary data
Journal Articles

Abstract IA17: Targeting the methylome for epigenetic resensitization of ovarian cancer

Kenneth P. Nephew, Daniela Matei, Pietro Taverna, Fang Fang, Jessica Tang, Gavin Choy, John Lyons, Mohammad Azab, Jay Pilrose, John Turchi
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): IA17.
https://doi.org/10.1158/1078-0432.OVCA13-IA17
Published: 13 May 2014
View article titled, Abstract IA17: Targeting the methylome for epigenetic resensitization of ovarian cancer
Journal Articles

Mammographic Breast Density Response to Aromatase Inhibition

Celine M. Vachon, Vera J. Suman, Kathleen R. Brandt, Matthew L. Kosel, Aman U. Buzdar, Janet E. Olson, Fang-Fang Wu, Lynn M. Flickinger, Giske Ursin, Catherine R. Elliott, Lois Shepherd, Richard M. Weinshilboum, Paul E. Goss, James N. Ingle
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2144–2153.
https://doi.org/10.1158/1078-0432.CCR-12-2789
Published: 15 April 2013
View article titled, Mammographic Breast Density Response to Aromatase Inhibition
Open the PDF for Mammographic Breast Density Response to Aromatase Inhibition in another window
Journal Articles

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

Antoinette R. Tan, Eric H. Rubin, Diana C. Walton, Dale E. Shuster, Y. Nancy Wong, Fang Fang, Simon Ashworth, Lee S. Rosen
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4213–4219.
https://doi.org/10.1158/1078-0432.CCR-09-0360
Published: 15 June 2009
View article titled, Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors
Open the PDF for Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies

Sanjay Goel, Alain C. Mita, Monica Mita, Eric K. Rowinsky, Quincy S. Chu, Nancy Wong, Christopher Desjardins, Fang Fang, Mendel Jansen, Dale E. Shuster, Sridhar Mani, Chris H. Takimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4207–4212.
https://doi.org/10.1158/1078-0432.CCR-08-2429
Published: 15 June 2009
View article titled, A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies
Open the PDF for A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies in another window
Includes: Supplementary data